Pomerantz LLP is investigating HCA Healthcare and some of its executives for possible securities fraud following the company's sharp reduction in its full-year 2026 profit forecast. The lowered guidance was due to an unfavorable shift in payer mix, which reduced revenue by about $400 million in Q2 2026. This announcement caused HCA's stock price to drop nearly 7% on July 14, 2026. Investors affected by this may consider joining the class action lawsuit being pursued by Pomerantz LLP.
HCA Healthcare shares are the subject of an investor investigation. For readers following health-sector stocks, here is Pluang's market snapshot as of Sep 17, 2026 21:11 WIB: Out of 91 priced US health stocks, 59 rose and 31 fell. Notable movers include TXG at USD 78.51 with a +8.02% change, SANA at USD 3.12 with +6.85%, and INO at USD 1.22 with +6.09%. Typical hold times range from 22 to 94 days, with varying buy/sell order activity.
Fluence Energy's stock price target was cut sharply from $15.00 to $4.00 by RBC Capital analyst Christopher Dendrinos after the company slashed its 2026 revenue forecast from $3.00 billion to $2.40 billion. The company now expects an adjusted EBITDA ...
Regency Centers reported solid Q2 2026 results with Funds From Operations (FFO) at $1.21 per share and a 3.8% growth in same-property Net Operating Income (NOI). The company raised its full-year guidance, signaling confidence in continued growth. Reg...
Ciena reported a 37% revenue increase to $1.67 billion and a 215% rise in adjusted EPS to $2.11 in its fiscal third quarter, driven by strong demand from AI and cloud infrastructure. The company is well positioned to benefit from the AI networking ma...
Maureen Gellerman, Chief Human Resources Officer at Five Below, sold 1,610 shares of the company, generating $401,000 from the transaction. This insider sale may indicate personal financial planning or portfolio rebalancing but does not necessarily r...
ON Semiconductor is focusing on advanced power-density technologies for AI data centers and electric vehicles, aiming for $2.5 billion revenue from AI alone by 2030. Despite a Neutral rating from UBS, the company introduced its Embedded Power Platfor...
